Therapeutic effect of reticuloendothelial system (RES)-avoiding liposomes containing a phospholipid analogue of 5-fluorouracil, dipalmitoylphosphatidylfluorouridine, in Meth A sarcoma-bearing mice.

@article{Doi1994TherapeuticEO,
  title={Therapeutic effect of reticuloendothelial system (RES)-avoiding liposomes containing a phospholipid analogue of 5-fluorouracil, dipalmitoylphosphatidylfluorouridine, in Meth A sarcoma-bearing mice.},
  author={K. Doi and N. Oku and T. Toyota and S. Shuto and A. Sakai and H. Itoh and S. Okada},
  journal={Biological \& pharmaceutical bulletin},
  year={1994},
  volume={17 10},
  pages={
          1414-6
        }
}
Reticuloendothelial system (RES)-avoiding liposomes are known to accumulate in tumor tissues due to passive targeting. Dipalmitoylphosphatidylfluorouridine (DPPF), a potent antitumor agent readily incorporated into the lipid bilayer, was embedded in RES-avoiding liposomes modified with a uronic acid derivative, palmityl-D-glucuronide (PGlcUA). The therapeutic effect of DPPF in PGlcUA-liposomes was examined in tumor-bearing mice. Free or liposomal DPPF was injected intravenously into BALB/c mice… Expand
Anticancer therapy using glucuronate modified long-circulating liposomes.
  • Oku
  • Medicine
  • Advanced drug delivery reviews
  • 1999
Liposomes modified with P-aminophenyl-α-D-mannopyranoside: a carrier for targeting cerebral functional regions in mice.
  • Zhong-fei Hao, Y. Cui, +11 authors C. Jiang
  • Biology, Medicine
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
  • 2013
Liposomalization of SN-38 as active metabolite of CPT-11.
...
1
2
3
...